Long-acting bronchodilators are used in asthma, so may also benefit people with bronchiectasis. However, there is no good evidence for this at present.
Vollständige Zusammenfassung lesen
Symptoms of bronchiectasis include chronic productive cough, wheeze, breathlessness and recurrent infections of the lower respiratory tract. Long-acting bronchodilators are being used more frequently in the management of people with this condition.
Zielsetzungen
To determine the effectiveness of long-acting bronchodilators in the management of bronchiectasis that is not due to cystic fibrosis.
Suchstrategie
We searched the Cochrane Airways Group Specialised Register of bronchiectasis trials. The latest searches were carried out in August 2010.
Auswahlkriterien
Randomised controlled trials, with or without masking.
Datensammlung und ‐analyse
The results of searches were reviewed against pre-specified criteria.
Hauptergebnisse
We were unable to identify any randomised controlled trials investigating the effectiveness of long-acting bronchodilator therapy in the management of bronchiectasis. An update search in August 2010 did not identify any new studies.
Schlussfolgerungen der Autoren
Further research is needed to establish if long-acting bronchodilators have a role in the management of people with bronchiectasis.
